Supraclavicular brachial plexus block with etidocaine without vasoconstrictor. Preliminary report.
When used for supraclavicular brachial plexus blocks, etidocaine 1% gave a quick and sufficient onset. Its duration was longer than that of mepivacaine 2%, and equal to that of bupivacaine 0.5%. Onset times for etidocaine 0.5% and bupivacaine 0.5% were about equal, but the former seemed to give a more profound motor block. The duration of etidocaine 0.5% was shorter than that of bupivacaine 0.5%. The long-acting agents showed great variations in duration, and they all had longer regression times than mepivacaine. No serious pharmacological side-effects were observed during this study, and so far there are no reports on neurological sequelae.
D000083:Acetanilides / Q000031:analogs & derivatives*; D000328:Adult; D000698:Analgesia; D001917:Brachial Plexus / Q000187:drug effects*; D002045:Bupivacaine / Q000494:pharmacology; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005041:Etidocaine / Q000494:pharmacology; D006801:Humans; D008619:Mepivacaine / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D009407:Nerve Block; D012677:Sensation / Q000187:drug effects; D013997:Time Factors
D000083:Acetanilides; D008619:Mepivacaine; D005041:Etidocaine; D002045:Bupivacaine